De novo lymphoid blastic phase chronic myeloid leukemia: report and contemporary discussion

De novo lymphoid blastic phase chronic myeloid leukemia: report and contemporary discussion

Objective: We herein describe two cases of de novo lymphoid blastic transformation in patients with no history of chronic-phase chronic myeloid leukemia (CP-CML), both of whom were labeled initially as Philadelphia positive B-Acute Lymphoblastic Leukemia (B-ALL).Methods: The first patient was an 18-...

Full description

Bibliographic Details
Main Authors: Maha Hameed, Mohammed Alnoamani, Mohammed Marei, Imran Tailor, Hassan Alshehri, Soha A. Tashkandi, Azizah Alswayyed, Abdullah M. Alrajhi, Syed Z. A. Zaidi, Ibraheem Motabi, Nawal AlShehry, Mansour Alfayez
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Hematology
Subjects:
Tyrosine kinase inhibitor
blastic phase CML
ponatinib
blinatumomab
sudden blastic transformation
BCR-ABL
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2022.2150386

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2022.2150386

Similar Items